G7 urged to donate ’emergency’ supplies to vaccine-sharing scheme By Reuters

G7 urged to donate ’emergency’ supplies to vaccine-sharing scheme By Reuters

G7 urged to donate 'emergency' supplies to vaccine-sharing scheme
© Reuters. FILE PHOTO: Vials labelled “AstraZeneca, Pfizer – Biontech, Johnson&Johnson, Sputnik V coronavirus disease (COVID-19) vaccine” are seen in this illustration picture taken May 2, 2021. REUTERS/Dado Ruvic/Illustration//File Photo

By Emma Farge

GENEVA (Reuters) – The head of UNICEF on Monday asked G7 countries to donate supplies to the COVAX vaccine-sharing scheme as an emergency measure to address a severe shortfall caused by disruption to Indian vaccine exports.

India has curbed exports of the AstraZeneca (NASDAQ:) vaccine made by its Serum Institute, which had been pledged to COVAX, to be used by the country as it battles a massive second wave of infections.

U.N. agency UNICEF, which is in charge of supplying coronavirus vaccines through COVAX, estimates the supply shortfall at 140 million doses by the end of May and about 190 million by the end of June.

“Sharing immediately available excess doses is a minimum, essential and emergency stop-gap measure, and it is needed right now,” said UNICEF Executive Director Henrietta Fore, adding that this could help to prevent vulnerable countries from becoming the next global hotspot.

As G7 leaders prepare to meet in Britain next month, the head of the World Health Organization last week denounced the “moral catastrophe” of vaccine inequity, urging wealthy countries to donate doses rather than use them for children who are less vulnerable to severe disease.

Citing new research from scientific information and analytics company Airfinity, UNICEF’s Fore said that G7 countries could donate about 153 million doses if they shared only 20% of their available supply over June, July and August.

This could be done while still meeting commitments to vaccinate their own populations, she said without providing further detail.

COVAX, run jointly by the WHO and the GAVI vaccine alliance, relies heavily on the AstraZeneca shot, which accounts for the bulk of the vaccines earmarked for early rollout as it seeks to provide 2 billion doses this year.

UNICEF said that other manufacturing limitations outside India had also slowed supply of COVAX doses but those delays are expected to be resolved by the end of June.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Source

Report

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings